Evidence Review Finds Aluminum-Adjuvant Vaccines Not Tied to Autism, Asthma or Type 1 Diabetes

Evidence review finds aluminum-adjuvant vaccines not tied to autism, asthma or type 1 diabetes

Current evidence does not support direct (causal) associations between aluminum-adjuvant vaccines and serious or long-term health outcomes, including autism, diabetes and asthma, finds a review of the latest data published by The BMJ.

Review Finds No Direct Connection Between Aluminium-Adjuvanted Vaccines and

A Comprehensive Examination of Aluminium Adjuvants in Vaccines Reveals No Causal Link to Serious Health Conditions In an extensive systematic review published today in The BMJ, researchers have delivered compelling evidence that aluminium salts used as adjuvants in vaccines do not cause serious or long-term health problems, including autism spectrum disorders, type 1 diabetes, or asthma. Despite widespread scrutiny over decades concerning vaccin…